ICIonut Costin

Ionut Costin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ionut Costin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Liver Viscosity Imaging and Disease Severity in Alcohol-Associated Hepatitis: A Prospective Cross-Sectional Pilot Study

    by Carmen-Georgeta Fierbințeanu-Braticevici, Priscila Mădălina Ologeanu, Ionuț-Cristian Costin, Andrei Cozea, Vlad-Teodor Enciu

    Background: Alcohol-associated hepatitis (AH) is an acute inflammatory phenotype of alcohol-associated liver disease associated with substantial short-term mortality. Established clinical scores quantify disease severity but do not directly characterize liver tissue mechanics. Ultrasound-derived viscosity-related measurements may provide complementary, non-invasive information on viscoelastic tissue behavior, although their biological determinants remain incompletely defined. Objective: We aimed to evaluate the association between liver viscosity and AH through the Sound Touch Visco-elastography Imaging (STVi) parameter and inflammatory, biochemical, and MDF-defined severity measures, and to explore its discriminatory performance. Methods: This prospective, single-center, cross-sectional pilot study included 62 patients with clinically diagnosed AH and 30 healthy volunteers. Participants underwent multiparametric ultrasound assessment using the Resona A20 platform with STVi, liver stiffness measurement, and attenuation imaging. Results: The viscosity-related parameter was higher in patients with AH than in healthy volunteers and was associated with liver stiffness, inflammatory markers, and MDF-defined severity. The exploratory AH-versus-healthy comparison yielded an AUC of 0.873 (95% CI, 0.797–0.934). Within the AH cohort, 28 patients had severe AH (MDF ≥ 32) and 34 had non-severe AH. For MDF-defined severe AH, the AUC was 0.863 (bootstrap 95% CI, 0.756–0.955). At the Youden-derived cutoff of 2.8 Pa·s, sensitivity was 78.6% and specificity was 94.1%. Conclusions: STVi provides a model-derived, platform-dependent viscosity-related parameter associated with inflammatory measures and clinical severity in AH. These preliminary findings suggest that liver viscosity imaging may represent a valuable new avenue for the non-invasive assessment of AH. However, standardized acquisition, longitudinal assessment, histological correlation, and external validation are required before clinical implementation.

  • Open Access

    Ailanthus altissima Allergy: Emerging Aeroallergen in the Field of Respiratory Allergies in Romania

    by Nicolae Ovidiu Berghi, Alina Gabriela Berghi, Mihai Dumitru, Alina Oancea, Alexandru-Darius Dragomir-Serboiu, Ionut Costin, Daniela Vrinceanu, Adina Zamfir Chiru Anton

    Respiratory allergies are among the most prevalent chronic diseases worldwide, and seasonal allergic rhinitis and asthma place a substantial burden on patients and healthcare systems. Pollen from trees, grasses, and weeds contribute to a wide spectrum of clinical manifestations, while globalization, urban landscaping, biological invasions, and climate change are facilitating the spread of new allergenic plants across continents. Ailanthus altissima (tree of heaven) is a fast-growing deciduous tree native to China that has become widely distributed in North America and Europe, including Romania. Although initially introduced as an ornamental and shade tree, its rapid growth, tolerance of pollution and drought, and ability to colonize disturbed urban habitats have increased its relevance as a potential aeroallergen. This narrative clinical review synthesizes evidence from clinical case reports, sensitization studies, molecular allergen characterization, aerobiological monitoring, and Romanian distribution data. To improve clinical and public health applicability, the review includes summary tables comparing Ailanthus with other emerging allergens such as ragweed and Platanus, outlining Romanian ecological and pollen-monitoring evidence, summarizing diagnostic implications for ENT and allergy practice, identifying evidence gaps, and presenting future research priorities. Current evidence supports A. altissima pollen as an emerging but under-recognized respiratory allergen, particularly in urban areas where the tree is established. However, major limitations remain, including the lack of standardized diagnostic extracts, incomplete molecular allergen validation, limited routine pollen monitoring, and absence of Romanian clinical sensitization studies. Greater clinical awareness, species-specific aerobiological surveillance, standardized allergen characterization, and coordinated Romanian sensitization studies are needed to determine the extent to which A. altissima pollen contributes to allergic rhinitis and asthma. Future research should explicitly distinguish species occurrence, airborne pollen exposure, IgE sensitization, and clinically relevant respiratory disease when evaluating the emerging allergenic importance of A. altissima.

  • Open Access

    The Relationship Between Eosinophilic Esophagitis and Laryngeal Manifestations: Pathophysiology, Clinical Overlap, and Diagnostic Challenges

    by Ionut Costin, Mihai Dumitru, Ovidiu Berghi, Daniela Vrinceanu, Alina Lavinia Antoaneta Oancea, Andrei Cozea, Alexandru Moldoveanu, Georgeta-Carmen Fierbinteanu-Braticevici

    Background: Eosinophilic esophagitis (EoE) is a chronic type 2 immune-mediated esophageal disease defined by esophageal dysfunction and eosinophil-predominant inflammation. Beyond classic gastrointestinal symptoms, patients may present with aerodigestive complaints such as chronic cough, hoarseness, recurrent croup, stridor, vocal fold abnormalities, and subglottic stenosis, creating diagnostic overlap with laryngopharyngeal reflux, vocal fold dysfunction, asthma, allergic rhinitis, and other airway disorders. Methods: This scoping review mapped evidence on the relationship between EoE and laryngeal manifestations. PubMed/MEDLINE was searched using terms related to EoE, laryngeal disease, reflux, vocal fold pathology, and subglottic stenosis. Human English-language case reports, case series, observational studies, clinical trials, and reviews were narratively charted by study design, population, diagnostic criteria, laryngeal findings, reflux evaluation, treatment, and outcomes. Results: Laryngeal involvement in EoE appears clinically relevant but remains incompletely characterized. Direct eosinophilic infiltration of laryngeal or hypopharyngeal tissue is rare, whereas indirect mechanisms—including shared type 2 inflammation, epithelial barrier dysfunction, eosinophil and mast-cell mediators, reflux or microaspiration, and comorbid atopic airway disease—may contribute to symptoms and lesions. Pediatric patients may be especially likely to show airway-predominant presentations, including recurrent croup, chronic cough, and subglottic stenosis. Evidence is limited by heterogeneous definitions, inconsistent laryngoscopy or biopsy, variable reflux testing, and small observational reports. Conclusions: EoE should be considered in persistent or recurrent laryngeal symptoms, particularly when refractory to reflux or airway-directed therapy or associated with atopy. Multidisciplinary evaluation may improve recognition and management. Future studies should use standardized laryngeal assessment, pediatric case–control designs, and biomarker approaches linking EoE activity with objective laryngeal findings.